U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
KELIXIMAB
62L6LCF5EU
Investigational
General
Record Details
Names
7
Identifiers
6
Active Moiety
1
Characteristic Attributes
2
KELIXIMAB
62L6LCF5EU
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
Record UNII
62L6LCF5EU
Record Status
Validated (UNII)
Record Version
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
KELIXIMAB
Official Name
English
keliximab [INN]
Common Name
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD4 (ANTIGEN)) (HUMAN-MACACA MONOCLONAL CE9.1 G1-CHAIN), DISULFIDE WITH HUMAN-MACACA MONOCLONAL CE9.1 L-CHAIN, DIMER
Common Name
English
Keliximab [WHO-DD]
Common Name
English
IDEC-CE9.1
Code
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
62L6LCF5EU
PRIMARY
WIKIPEDIA
Keliximab
PRIMARY
CAS
174722-30-6
PRIMARY
NCI_THESAURUS
C188517
PRIMARY
INN
7560
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
62L6LCF5EU
KELIXIMAB
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED
Showing 1 to 2 of 2 entries
Previous
1
Next
